Trade

with

NuVasive Inc
(NASDAQ: NUVA)
AdChoices
36.30
-0.21
-0.58%
After Hours :
36.30
0.00
0.00%

Open

36.75

Previous Close

36.51

Volume (Avg)

138.05k (314.62k)

Day's Range

36.25-37.05

52Wk Range

25.07-39.89

Market Cap.

1.71B

Dividend Rate ( Yield )

-

Beta

1.12

Shares Outstanding

46.98M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 685.17M

    • Net Income

    • 7.90M

    • Market Cap.

    • 1.71B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1.21

    • PEG (Price/Earnings Growth) Ratio

    • 1.17

    • Beta

    • 1.12

    • Forward P/E

    • 24.39

    • Price/Sales

    • 2.38

    • Price/Book Value

    • 2.75

    • Price/Cash flow

    • 14.93

      • EBITDA

      • 100.05M

      • Return on Capital %

      • -0.75

      • Return on Equity %

      • -1.52

      • Return on Assets %

      • -0.75

      • Book Value/Share

      • 13.19

      • Shares Outstanding

      • 46.98M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 46.00

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • 0.49

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 15.10

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • 151.30

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 22.33

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 75.17

            • 64.08

            • Pre-Tax Margin

            • -2.64

            • 15.19

            • Net Profit Margin

            • -1.21

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 78.80

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -1.60

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 1.30

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.57

              • 0.34

              • Current Ratio

              • 3.69

              • 2.55

              • Quick Ratio

              • 2.39

              • 1.83

              • Interest Coverage

              • 0.30

              • 11.70

              • Leverage Ratio

              • 2.02

              • 1.86

              • Book Value/Share

              • 13.19

              • 11.67

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -181.82

                • 35.09

                • P/E Ratio 5-Year High

                • -240.99

                • 224.03

                • P/E Ratio 5-Year Low

                • -56.71

                • 60.23

                • Price/Sales Ratio

                • 2.32

                • 3.24

                • Price/Book Value

                • 2.68

                • 3.29

                • Price/Cash Flow Ratio

                • 14.93

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -1.52

                    (2.20)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • -0.75

                    (1.10)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 0.96

                    (-0.20)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • -

                  • 34.11k

                  • Inventory Turnover

                  • 1.23

                  • 2.77

                  • Asset Turnover

                  • 0.62

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  33.09M
                  Operating Margin
                  4.83
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  14.93
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  43.92%

                  Mutual Fund Ownership

                  64.44%

                  Float

                  88.14%

                  5% / Insider Ownership

                  8.05%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica New Economy

                  •  

                    3,028,700

                  • 0.51

                  • 6.45

                  • VA CollegeAmerica Small Cap World

                  •  

                    1,702,936

                  • 0.70

                  • 3.63

                  • Champlain - Small Cap Equity

                  •  

                    1,684,410

                  • -2.18

                  • 3.59

                  • Vanguard Health Care Fund

                  •  

                    1,628,303

                  • 0.00

                  • 3.47

                  • Federated Kaufmann Fund

                  •  

                    1,322,000

                  • 0.00

                  • 2.82

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    948,257

                  • 0.20

                  • 2.11

                  • Vanguard Small Cap Index

                  •  

                    816,036

                  • 0.45

                  • 1.74

                  • Vanguard Total Stock Mkt Idx

                  •  

                    759,281

                  • 0.37

                  • 1.62

                  • iShares Russell 2000 (AU)

                  •  

                    691,785

                  • -1.46

                  • 1.54

                  • Champlain Small Company Fund

                  •  

                    625,000

                  • 6.84

                  • 1.33

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Capital Research Global Investors

                  •  

                    4,209,836

                  • +7.34%

                  • 8.97

                  • Vanguard Group, Inc.

                  •  

                    3,080,694

                  • +0.96%

                  • 6.56

                  • BlackRock Fund Advisors

                  •  

                    2,505,074

                  • -2.49%

                  • 5.34

                  • Champlain Investment Partners, LLC

                  •  

                    1,854,740

                  • +1.01%

                  • 3.95

                  • Federated Global Inv Mgmt Corp

                  •  

                    1,712,400

                  • +791.88%

                  • 3.65

                  • Wellington Management Company, LLP

                  •  

                    1,628,526

                  • +0.01%

                  • 3.47

                  • NORTH TIDE CAPITAL LLC

                  •  

                    1,500,000

                  • 0.00%

                  • 3.20

                  • Healthcor Management, L.p.

                  •  

                    1,450,000

                  • +45.00%

                  • 3.09

                  • Dimensional Fund Advisors, Inc.

                  •  

                    1,406,045

                  • +5.15%

                  • 3.00

                  • Invesco Advisers, Inc

                  •  

                    1,262,278

                  • -2.59%

                  • 2.69

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Aggressive Growth

                  Style

                  Small Growth

                  Nuvasive Inc. was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. It is a medical device company engaged in developing minimally disruptive surgical products and procedures for the spine. Th...moree Company’s current-marketed product portfolio is engaged in applications for spine fusion surgery, including biologics. The Company's product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS®. The MAS platform combines three categories of solutions that collectively minimize soft tissue disruption during spine fusion surgery, provide maximum visualization and are designed to enable safe and reproducible outcomes for the surgeon and the patient. The platform includes its proprietary software-driven nerve detection and avoid...moreance systems, NVM5 and NVJJB, and Intra-Operative Monitoring (IOM) support; MaXcess®, an integrated split-blade retractor system; and a variety of specialized implants. The Company’s primary business model is to loan its MAS systems to surgeons and hospitals who purchase implants, biologics and disposables for use in individual procedures. In addition, for larger customers, the Company’s proprietary nerve monitoring systems, MaXcess and surgical instrument sets are placed with hospitals for an extended period at no up-front cost to them. The Company also offers a range of bone allograft in patented saline packaging, disposables and spine implants, which include its branded CoRoent® products and fixation devices such as rods, plates and screws. Implants, biologics and disposables are shipped from the Company’s inventories. The Company sells an immaterial quantity of MAS instrument sets, MaXcess and nerve monitoring systems to hospitals. Its spine surgery product line offerings, which include products for the thoracolumbar and the cervical spine, are used to enable access to the spine and to perform restoration and fusion procedures in a minimally disruptive fashion. In the United States, it currently sells its products through a combination of exclusive independent sales agencies and directly-employed sales shareowners. The Company has 230 issued U.S. patents, 165 foreign national patents, and 284 pending patent applications. The Company's competitors are Medtronic Sofamor Danek (Medtronic), DePuy/Synthes, a Johnson & Johnson company, Stryker Spine, Globus Medical, Biomet Spine, and Zimmer Spine. It also faces competition from physician owned distributorships (PODs), which are medical device distributors that are owned, directly or indirectly, by physicians. The Company’s products,medical devices and tissues subject to regulation by the FDA and other regulatory bodies.lessless

                  Key People

                  Alexis V. Lukianov

                  CEO/Chairman of the Board/Director

                  Quentin Blackford

                  Executive VP, Divisional/Chief Accounting Officer/CFO

                  Jason M. Hannon

                  Secretary/General Counsel/Executive VP, Divisional

                  Mr. Russell Powers

                  Executive VP, Divisional

                  Mr. Matthew Link

                  Executive VP, Divisional

                  • NuVasive Inc

                  • 7475 Lusk Boulevard

                  • San Diego, CA 92121

                  • USA.Map

                  • Phone: +1 858 909-1800

                  • Fax: +1 800 475-9134

                  • nuvasive.com

                  Incorporated

                  1997

                  Employees

                  1,358

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: